The Cables gene on chromosome 18q regulates colon cancer progression in vivo

Cancer Biology and Therapy

Volumn 4, Issue 8, 2005, Pages 861-863

  Kirley, Sandra D ^a   D'Apuzzo, Massimo ^a   Lauwers, Gregory Y ^a   Graeme Cook, Fiona ^a   Chung, Daniel C ^a   Zukerberg, Lawrence R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cables1; Candidate tumor suppressor gene; Chromosome 18q; Colorectal cancer

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CABLES PROTEIN; GENE PRODUCT; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHROMOSOME 18Q; CHROMOSOME DELETION; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; REGULATOR GENE; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

EID: 25144465523     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.8.1894     Document Type: Article

References (21)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:59-767.
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525-32.
3. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247:49-56.
4. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markowitz S, Hamilton SR, Kern SE, Kinzler KW, Vogelstein B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996; 13:343-6.
5. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, Hedge P, Silverman GA, Vogelstein B. The DCC gene: Structural analysis and mutations in colorectal carcinomas. Genomics 1994; 19:525-31.
6. Keino-Masu K, Masu M, Hinck L, Leonardo E, Chan S, Culotti J, Tessier-Lavigne M. Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell 1996; 87:175-85.
7. Gotley D, Reeder J, Fawcett J, Walsh M, Bates P, Simmons D, Antalis TM. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene 1996; 13:787-95.
8. Fazeli A, Dickinson SLO, Hermiston ML, Tighe RV, Steen RG, Small CGM, Stoeckli E, Keino-Masu K, Rayburn H, Simons J, Bronson RT, Gordon JI, Tessier-Lavigne M, Weinberg RA. Phenotype of mice lacking functional deleted in colorectal cancer (DCC) gene. Nature 1997; 386:796-804.
9. Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, Gespach C, Bresden DE, Soazec JY, Mehlen P. Netrin-1 controls tumorigenesis by regulating apoptosis. Nature 2004; 431:80-4.
10. Hahn SA, Schutte M, Hoque A, Schutte M, Moskaluk CA, Da Costa LT, Rosenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. DPC4 a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271:350-3.
11. Takagi Y, Kohmura H, Futamura M, Kida H, Tanemura H, Shimokawa K, Saji S. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 1996; 111:1369-72.
12. Takagi Y, Kohmura H, Futamura M, Aoki S, Ymaguchi K, Kida H, Tanemura H, Shimokawa K, Saji S. Somatic alterations of the SMAD-2 gene in human colorectal cancers. Br J Cancer 1998; 78:1152-5.
13. Eppert K, Scherer S, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L, bapat B, Gallinger S, Andrulis IL, Thompsen G, Wrana J, Attisano L. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD related protein that is functionally mutated in colorectal carcinoma. Cell 1996; 86:543-52.
14. Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu C-L, Lanier LM, Gertler FB, Vidal M, Van Etten RA, Tsai L-H. Cables links cdk5 and c-Abl and facilitates cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 2000; 26:633-46.
15. Matsuoka M, Matsuura Y, Semba K, Nishimoto I. Molecular cloning of a cyclin-like protein associated with cyclin dependent kinase 3 (cdk3) in vivo. Biochem Biophys Res Comm 2000; 273:442-7.
16. Tsuji K, Mizumoto K. Yamochi T, Nishimoto I, Matsuoka M. Differential effect of ik3-1/Cables on p53 and p73-induced cell death. J Biol Chem 2002; 277:2951-7.
17. Wu CL, Kirley S, Xiao H, Chuang Y, Chung DC, Zukerberg LR. Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers. Cancer Res 2001; 61:7325-32.
18. Zukerberg LR, DeBernardo RL, Kirley SD, D'Apuzzo M, Lynch MP, Littell RD, duska LR, Doring L, Rueda BR. Loss of Cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer. Cancer Res 2004; 64:202-8.
19. Thurnherr N, Deschner E, Stonehill E, Lipkin M. Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine. Cancer Res 1973; 33:940-5.
20. Diwan B, Meier H, Blackman E. Genetic differences in the induction of colorectal tumors by 1,2-dimethylhydrazine in inbred mice. J National Cancer Institute 1977; 59:455-457.
21. Kuraguchi M, Cook H, Williams E, Thomas G. Differences in susceptibility to colonic stem cell somatic mutation in three strains of mice. J Pathology 2001; 193:517-21.